{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T13:53:35Z","timestamp":1792850015072,"version":"4.5.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000027","name":"U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["Y1AA3009"],"award-info":[{"award-number":["Y1AA3009"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Dopamine (DA) neurotransmission is critical in the neurobiology of reward and aversion, but its contribution to the aversive state of opioid withdrawal remains unknown in humans. To address this, we used updated voxelwise methods and retrospectively analyzed a [<jats:sup>11<\/jats:sup>C]raclopride-PET dataset to measure D<jats:sub>2\/3<\/jats:sub>receptor availability and relative cerebral blood flow (R1) in male opioid use disorder (OUD) participants (<jats:italic>n<\/jats:italic>\u2009=\u200910) during placebo and acute opioid withdrawal conditions. We found that acute withdrawal precipitated by the opioid antagonist naloxone significantly increased dorsal striatal DA release in OUD participants (<jats:italic>p<\/jats:italic><jats:sub>FWE<\/jats:sub>\u2009&lt;\u20090.05). Net changes in striatal DA were significantly correlated with a subjective index of withdrawal aversion such that greater DA increases were associated with more aversive responses (<jats:italic>r<\/jats:italic>(8)\u2009=\u20090.82,<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.005). Withdrawal also affected brain function, as indexed by increases in relative cerebral blood flow in the insula and putamen (<jats:italic>p<\/jats:italic><jats:sub>FWE<\/jats:sub>\u2009&lt;\u20090.05). Our findings are different from preclinical studies that have primarily reported decreases in ventral striatal DA during naloxone precipitated withdrawal, whereas this effect was not significant in OUD participants (<jats:italic>p<\/jats:italic>\u2009=\u20090.79). In sum, we provide evidence for the contribution of increases in dorsal striatal DA to the aversive state of naloxone precipitated withdrawal in humans.<\/jats:p>","DOI":"10.1038\/s41398-021-01548-8","type":"journal-article","created":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T09:04:08Z","timestamp":1630487048000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Naloxone precipitated withdrawal increases dopamine release in the dorsal striatum of opioid dependent men"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6846-3173","authenticated-orcid":false,"given":"Ehsan","family":"Shokri-Kojori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene-Jack","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6668-0908","authenticated-orcid":false,"given":"Nora D.","family":"Volkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,1]]},"reference":[{"key":"1548_CR1","doi-asserted-by":"publisher","unstructured":"Cox B.M. Opioid Receptor-G Protein Interactions: Acute and Chronic Effects of Opioids. In: Herz A., Akil H., Simon E.J. (eds) Opioids. Handbook of Experimental Pharmacology, vol 104 \/ 1. Springer: Berlin, Heidelberg, 1993, pp 145\u2013188, https:\/\/doi.org\/10.1007\/978-3-642-77460-7_8.","DOI":"10.1007\/978-3-642-77460-7_8"},{"key":"1548_CR2","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1152\/physrev.00005.2009","volume":"89","author":"JL Merrer","year":"2009","unstructured":"Merrer JL, Becker JAJ, Befort K, Kieffer BL. Reward processing by the opioid system in the brain. Physiol Rev. 2009;89:1379\u2013412.","journal-title":"Physiol Rev"},{"key":"1548_CR3","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.neuron.2015.04.015","volume":"86","author":"M Pignatelli","year":"2015","unstructured":"Pignatelli M, Bonci A. Role of dopamine neurons in reward and aversion: a synaptic plasticity perspective. Neuron. 2015;86:1145\u201357.","journal-title":"Neuron"},{"key":"1548_CR4","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nrn.2017.130","volume":"18","author":"ND Volkow","year":"2017","unstructured":"Volkow ND, Wise RA, Baler R. The dopamine motive system: implications for drug and food addiction. Nat Rev Neurosci. 2017;18:741\u201352.","journal-title":"Nat Rev Neurosci"},{"key":"1548_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.neuropharm.2008.05.022","volume":"56","author":"N Volkow","year":"2009","unstructured":"Volkow N, Fowler J, Wang G, Baler R, Telang F. Imaging dopamine\u2019s role in drug abuse and addiction. Neuropharmacology. 2009;56:3\u20138.","journal-title":"Neuropharmacology"},{"key":"1548_CR6","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S0893-133X(96)00184-4","volume":"16","author":"G-J Wang","year":"1997","unstructured":"Wang G-J, Volkow ND, Fowler JS, Logan J, Abumrad NN, Hitzemann RJ, et al. Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal. Neuropsychopharmacology. 1997;16:174\u201382.","journal-title":"Neuropsychopharmacology"},{"key":"1548_CR7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.biopsych.2011.08.024","volume":"71","author":"D Martinez","year":"2012","unstructured":"Martinez D, Saccone PA, Liu F, Slifstein M, Orlowska D, Grassetti A, et al. Deficits in dopamine D2 receptors and presynaptic dopamine in heroin dependence: commonalities and differences with other types of addiction. Biol Psychiatry. 2012;71:192\u20138.","journal-title":"Biol Psychiatry"},{"key":"1548_CR8","first-page":"1236","volume":"266","author":"DP Devine","year":"1993","unstructured":"Devine DP, Leone P, Pocock D, Wise R. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. J Pharmacol Exp Ther. 1993;266:1236\u201346.","journal-title":"J Pharmacol Exp Ther"},{"key":"1548_CR9","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1038\/npp.2013.171","volume":"38","author":"VI Chefer","year":"2013","unstructured":"Chefer VI, B\u00e4ckman CM, Gigante ED, Shippenberg TS. Kappa opioid receptors on dopaminergic neurons are necessary for Kappa-mediated place aversion. Neuropsychopharmacology. 2013;38:2623\u201331.","journal-title":"Neuropsychopharmacology"},{"key":"1548_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/BF02244761","volume":"115","author":"R Spanagel","year":"1994","unstructured":"Spanagel R, Almeida OF, Bartl C, Shippenberg TS. Endogenous \u03ba-opioid systems in opiate withdrawal: role in aversion and accompanying changes in mesolimbic dopamine release. Psychopharmacology. 1994;115:121\u20137.","journal-title":"Psychopharmacology"},{"key":"1548_CR11","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0091-3057(81)90398-1","volume":"14","author":"J Nazzaro","year":"1981","unstructured":"Nazzaro J, Seeger T, Gardner E. Morphine differentially affects ventral tegmental and substantia nigra brain reward thresholds. Pharmacol Biochem Behav. 1981;14:325\u201331.","journal-title":"Pharmacol Biochem Behav"},{"key":"1548_CR12","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2174\/157015908785777229","volume":"6","author":"ER Samuels","year":"2008","unstructured":"Samuels ER, Szabadi E. Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part I: principles of functional organisation. Curr Neuropharmacol. 2008;6:235\u201353.","journal-title":"Curr Neuropharmacol"},{"key":"1548_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1151\/spp021113","volume":"1","author":"TR Kosten","year":"2002","unstructured":"Kosten TR, George TP. The neurobiology of opioid dependence: implications for treatment. Sci Pract Perspect. 2002;1:13\u201320.","journal-title":"Sci Pract Perspect"},{"key":"1548_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0079-6123(08)63810-8","volume":"88","author":"K Rasmussen","year":"1991","unstructured":"Rasmussen K. Afferent effects on locus coeruleus in opiate withdrawal. Prog Brain Res. 1991;88:207\u201316.","journal-title":"Prog Brain Res"},{"key":"1548_CR15","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1007\/s11064-013-1091-3","volume":"38","author":"Y Zhou","year":"2013","unstructured":"Zhou Y, Leri F, Ho A, Kreek MJ. Suppression of hypothalamic\u2013pituitary\u2013adrenal axis by acute heroin challenge in rats during acute and chronic withdrawal from chronic heroin administration. Neurochem Res. 2013;38:1850\u201360.","journal-title":"Neurochem Res"},{"key":"1548_CR16","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1124\/jpet.106.118810","volume":"321","author":"D Wang","year":"2007","unstructured":"Wang D, Sun X, Sadee W. Different effects of opioid antagonists on \u03bc-, \u03b4-, and \u03ba-opioid receptors with and without agonist pretreatment. J Pharmacol Exp Ther. 2007;321:544\u201352.","journal-title":"J Pharmacol Exp Ther"},{"key":"1548_CR17","first-page":"330","volume":"45","author":"K Raynor","year":"1994","unstructured":"Raynor K, Kong H, Chen Y, Yasuda K, Yu L, Bell GI, et al. Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. Mol Pharmacol. 1994;45:330\u20134.","journal-title":"Mol Pharmacol"},{"key":"1548_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13643-019-1048-y","volume":"8","author":"LV Shaw","year":"2019","unstructured":"Shaw LV, Moe J, Purssell R, Buxton JA, Godwin J, Doyle-Waters MM, et al. Naloxone interventions in opioid overdoses: a systematic review protocol. Syst Rev. 2019;8:1\u20139.","journal-title":"Syst Rev"},{"key":"1548_CR19","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1016\/S0021-9258(17)38065-1","volume":"253","author":"MG Caron","year":"1978","unstructured":"Caron MG, Beaulieu M, Raymond V, Gagn\u00e9 B, Drouin J, Lefkowitz RJ, et al. Dopaminergic receptors in the anterior pituitary gland. Correlation of [3H] dihydroergocryptine binding with the dopaminergic control of prolactin release. J Biol Chem. 1978;253:2244\u201353.","journal-title":"J Biol Chem"},{"key":"1548_CR20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41386-019-0395-7","volume":"45","author":"LJ Boulos","year":"2020","unstructured":"Boulos LJ, Ben Hamida S, Bailly J, Maitra M, Ehrlich AT, Gav\u00e9riaux-Ruff C, et al. Mu opioid receptors in the medial habenula contribute to naloxone aversion. Neuropsychopharmacology. 2020;45:247\u201355.","journal-title":"Neuropsychopharmacology"},{"key":"1548_CR21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0014-2999(91)90214-B","volume":"193","author":"E Acquas","year":"1991","unstructured":"Acquas E, Carboni E, Di Chiara G. Profound depression of mesolimbic dopamine release after morphine withdrawal in dependent rats. Eur J Pharm. 1991;193:133\u20134.","journal-title":"Eur J Pharm"},{"key":"1548_CR22","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/0006-8993(91)91724-F","volume":"566","author":"E Pothos","year":"1991","unstructured":"Pothos E, Rada P, Mark GP, Hoebel BG. Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment. Brain Res. 1991;566:348\u201350.","journal-title":"Brain Res"},{"key":"1548_CR23","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0014-2999(92)90706-A","volume":"221","author":"ZL Rossetti","year":"1992","unstructured":"Rossetti ZL, Hmaidan Y, Gessa GL. Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur J Pharm. 1992;221:227\u201334.","journal-title":"Eur J Pharm"},{"key":"1548_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0304-3940(01)02564-2","volume":"320","author":"Q Zhou","year":"2002","unstructured":"Zhou Q, Nyberg F. Injection of substance P (SP) N-terminal fragment SP(1-7) into the ventral tegmental area modulates the levels of nucleus accumbens dopamine and dihydroxyphenylacetic acid in male rats during morphine withdrawal. Neurosci Lett. 2002;320:117\u201320.","journal-title":"Neurosci Lett"},{"key":"1548_CR25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00210-003-0773-9","volume":"368","author":"L Stella","year":"2003","unstructured":"Stella L, De Novellis V, Vitelli MR, Capuano A, Mazzeo F, Berrino L, et al. Interactive role of adenosine and dopamine in the opiate withdrawal syndrome. Naunyn-Schmiedeberg\u2019s Arch Pharmacol. 2003;368:113\u20138.","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"1548_CR26","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1097\/00001756-199308000-00012","volume":"4","author":"PH Silverstone","year":"1993","unstructured":"Silverstone PH, Done C, Sharp T. In vivo monoamine release during naloxone-precipitated morphine withdrawal. Neuroreport. 1993;4:1043\u20135.","journal-title":"Neuroreport"},{"key":"1548_CR27","first-page":"558","volume":"187","author":"E Iwamoto","year":"1973","unstructured":"Iwamoto E, Ho I, Way EL. Elevation of brain dopamine during naloxone-precipitated withdrawal in morphine-dependent mice and rats. J Pharmacol Exp Ther. 1973;187:558\u201367.","journal-title":"J Pharmacol Exp Ther"},{"key":"1548_CR28","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.biopsych.2019.03.965","volume":"86","author":"PA Spagnolo","year":"2019","unstructured":"Spagnolo PA, Kimes A, Schwandt ML, Shokri-Kojori E, Thada S, Phillips KA. et al. Striatal dopamine release in response to morphine: a [11C]-raclopride positron emission tomography study in healthy men. Biol Psychiatry. 2019;86:356\u2013364.","journal-title":"Biol Psychiatry"},{"key":"1548_CR29","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.neuroimage.2011.09.015","volume":"62","author":"M Jenkinson","year":"2012","unstructured":"Jenkinson M, Beckmann CF, Behrens TEJ, Woolrich MW, Smith SM. FSL. NeuroImage. 2012;62:782\u201390.","journal-title":"NeuroImage"},{"key":"1548_CR30","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1006\/cbmr.1996.0014","volume":"29","author":"RW Cox","year":"1996","unstructured":"Cox RW. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res. 1996;29:162\u201373.","journal-title":"Comput Biomed Res"},{"key":"1548_CR31","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1097\/01.WCB.0000033967.83623.34","volume":"22","author":"Y Wu","year":"2002","unstructured":"Wu Y, Carson RE. Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging. J Cereb Blood Flow Metab. 2002;22:1440\u201352.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1548_CR32","doi-asserted-by":"publisher","first-page":"393","DOI":"10.2967\/jnumed.110.083683","volume":"52","author":"PT Meyer","year":"2011","unstructured":"Meyer PT, Hellwig S, Amtage F, Rottenburger C, Sahm U, Reuland P, et al. Dual-biomarker imaging of regional cerebral amyloid load and neuronal activity in dementia with PET and 11C-labeled Pittsburgh compound B. J Nucl Med. 2011;52:393\u2013400.","journal-title":"J Nucl Med"},{"key":"1548_CR33","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.2967\/jnumed.114.152405","volume":"56","author":"YJ Chen","year":"2015","unstructured":"Chen YJ, Rosario BL, Mowrey W, Laymon CM, Lu X, Lopez OL, et al. Relative 11C-PiB delivery as a proxy of relative CBF: quantitative evaluation using single-session 15O-water and 11C-PiB PET. J Nucl Med. 2015;56:1199\u2013205.","journal-title":"J Nucl Med"},{"key":"1548_CR34","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1177\/0271678X19830537","volume":"40","author":"M Bilgel","year":"2020","unstructured":"Bilgel M, Beason-Held L, An Y, Zhou Y, Wong DF, Resnick SM. Longitudinal evaluation of surrogates of regional cerebral blood flow computed from dynamic amyloid PET imaging. J Cereb Blood Flow Metab. 2020;40:288\u201397.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1548_CR35","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.neuroimage.2010.04.274","volume":"52","author":"PR Stokes","year":"2010","unstructured":"Stokes PR, Egerton A, Watson B, Reid A, Breen G, Lingford-Hughes A, et al. Significant decreases in frontal and temporal [11C]-raclopride binding after THC challenge. NeuroImage. 2010;52:1521\u20137.","journal-title":"NeuroImage"},{"key":"1548_CR36","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1006\/nimg.1995.1007","volume":"2","author":"KJ Friston","year":"1995","unstructured":"Friston KJ, Holmes AP, Poline JB, Grasby PJ, Williams SC, Frackowiak RS, et al. Analysis of fMRI time-series revisited. NeuroImage. 1995;2:45\u201353.","journal-title":"NeuroImage"},{"key":"1548_CR37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1006\/nimg.1996.0248","volume":"5","author":"J-B Poline","year":"1997","unstructured":"Poline J-B, Worsley KJ, Evans AC, Friston KJ. Combining spatial extent and peak intensity to test for activations in functional imaging. Neuroimage. 1997;5:83\u201396.","journal-title":"Neuroimage"},{"key":"1548_CR38","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1093\/cercor\/bhs397","volume":"24","author":"AC Tziortzi","year":"2014","unstructured":"Tziortzi AC, Haber SN, Searle GE, Tsoumpas C, Long CJ, Shotbolt P, et al. Connectivity-based functional analysis of dopamine release in the striatum using diffusion-weighted MRI and positron emission tomography. Cereb Cortex. 2014;24:1165\u201377.","journal-title":"Cereb Cortex"},{"key":"1548_CR39","first-page":"4498","volume":"83","author":"YR Smith","year":"1998","unstructured":"Smith YR, Zubieta JK, del Carmen MG, Dannals RF, Ravert HT, Zacur HA, et al. Brain opioid receptor measurements by positron emission tomography in normal cycling women: relationship to luteinizing hormone pulsatility and gonadal steroid hormones 1. J Clin Endocrinol Metab. 1998;83:4498\u2013505.","journal-title":"J Clin Endocrinol Metab"},{"key":"1548_CR40","doi-asserted-by":"publisher","first-page":"4190.","DOI":"10.3390\/molecules24224190","volume":"24","author":"P Cumming","year":"2019","unstructured":"Cumming P, Marton J, Lilius TO, Olberg DE, Rominger A. A survey of molecular imaging of opioid receptors. Molecules. 2019;24:4190.","journal-title":"Molecules"},{"key":"1548_CR41","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuroimage.2013.03.012","volume":"76","author":"HK Huynh","year":"2013","unstructured":"Huynh HK, Willemsen ATM, Holstege G. Female orgasm but not male ejaculation activates the pituitary. A PET-neuro-imaging study. NeuroImage. 2013;76:178\u201382.","journal-title":"NeuroImage"},{"key":"1548_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41597-019-0034-5","volume":"6","author":"P Mouches","year":"2019","unstructured":"Mouches P, Forkert ND. A statistical atlas of cerebral arteries generated using multi-center MRA datasets from healthy subjects. Sci Data. 2019;6:29.","journal-title":"Sci Data"},{"key":"1548_CR43","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3389\/fnins.2019.00120","volume":"13","author":"P Rucker","year":"2019","unstructured":"Rucker P, Ikuta T. Pituitary gland functional connectivity and BMI. Front Neurosci. 2019;13:120","journal-title":"Front Neurosci"},{"key":"1548_CR44","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.neuroscience.2014.07.053","volume":"277","author":"O Gardon","year":"2014","unstructured":"Gardon O, Faget L, Chu Sin Chung P, Matifas A, Massotte D, Kieffer BL. Expression of mu opioid receptor in dorsal diencephalic conduction system: new insights for the medial habenula. Neuroscience. 2014;277:595\u2013609.","journal-title":"Neuroscience"},{"key":"1548_CR45","doi-asserted-by":"crossref","unstructured":"Chen C, Willhouse AH, Huang P, Ko N, Wang Y, Xu B, et al. Characterization of a knock-in mouse line expressing a fusion protein of \u03ba opioid receptor conjugated with tdTomato: 3-dimensional brain imaging via CLARITY. eNeuro 2020; 7: ENEURO.0028-0020.2020.","DOI":"10.1523\/ENEURO.0028-20.2020"},{"key":"1548_CR46","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s41380-019-0369-5","volume":"24","author":"I Lazaridis","year":"2019","unstructured":"Lazaridis I, Tzortzi O, Weglage M, M\u00e4rtin A, Xuan Y, Parent M, et al. A hypothalamus-habenula circuit controls aversion. Mol Psychiatry. 2019;24:1351\u201368.","journal-title":"Mol Psychiatry"},{"key":"1548_CR47","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1523\/JNEUROSCI.06-03-00613.1986","volume":"6","author":"GR Christoph","year":"1986","unstructured":"Christoph GR, Leonzio RJ, Wilcox KS. Stimulation of the lateral habenula inhibits dopamine-containing neurons in the substantia nigra and ventral tegmental area of the rat. J Neurosci. 1986;6:613\u20139.","journal-title":"J Neurosci"},{"key":"1548_CR48","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/nature11527","volume":"491","author":"S Lammel","year":"2012","unstructured":"Lammel S, Lim BK, Ran C, Huang KW, Betley MJ, Tye KM, et al. Input-specific control of reward and aversion in the ventral tegmental area. Nature. 2012;491:212\u20137.","journal-title":"Nature"},{"key":"1548_CR49","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.neuroimage.2012.08.076","volume":"64","author":"RP Lawson","year":"2013","unstructured":"Lawson RP, Drevets WC, Roiser JP. Defining the habenula in human neuroimaging studies. Neuroimage. 2013;64:722\u20137.","journal-title":"Neuroimage"},{"key":"1548_CR50","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc: Ser B. 1995;57:289\u2013300.","journal-title":"J R Stat Soc: Ser B"},{"key":"1548_CR51","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0014-2999(94)90598-3","volume":"252","author":"GH Tjon","year":"1994","unstructured":"Tjon GH, De Vries TJ, Ronken E, Hogenboom F, Wardeh G, Mulder AH, et al. Repeated and chronic morphine administration causes differential long-lasting changes in dopaminergic neurotransmission in rat striatum without changing its \u03b4- and \u03ba-opioid receptor regulation. Eur J Pharmacol. 1994;252:205\u201312.","journal-title":"Eur J Pharmacol"},{"key":"1548_CR52","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/S0028-3908(98)00093-8","volume":"37","author":"K Grasing","year":"1998","unstructured":"Grasing K, Ghosh S. Selegiline prevents long-term changes in dopamine efflux and stress immobility during the second and third weeks of abstinence following opiate withdrawal. Neuropharmacology. 1998;37:1007\u201317.","journal-title":"Neuropharmacology"},{"key":"1548_CR53","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1038\/sj.npp.1300493","volume":"29","author":"A Erhardt","year":"2004","unstructured":"Erhardt A, Sillaber I, Welt T, M\u00fcller MB, Singewald N, Keck ME. Repetitive transcranial magnetic stimulation increases the release of dopamine in the nucleus accumbens shell of morphine-sensitized rats during abstinence. Neuropsychopharmacology. 2004;29:2074\u201380.","journal-title":"Neuropsychopharmacology"},{"key":"1548_CR54","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.bbi.2009.01.014","volume":"23","author":"ST Bland","year":"2009","unstructured":"Bland ST, Hutchinson MR, Maier SF, Watkins LR, Johnson KW. The glial activation inhibitor AV411 reduces morphine-induced nucleus accumbens dopamine release. Brain Behav Immun. 2009;23:492\u20137.","journal-title":"Brain Behav Immun"},{"key":"1548_CR55","first-page":"602","volume":"185","author":"Y Maruyama","year":"1973","unstructured":"Maruyama Y, Takemori AE. The role of dopamine and norepinephrine in the naloxone-induced abstinence of morphine-dependent mice. J Pharm Exp Ther. 1973;185:602\u20138.","journal-title":"J Pharm Exp Ther"},{"key":"1548_CR56","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1073\/pnas.89.6.2046","volume":"89","author":"R Spanagel","year":"1992","unstructured":"Spanagel R, Herz A, Shippenberg TS. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci USA. 1992;89:2046\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1548_CR57","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1038\/npp.2013.58","volume":"38","author":"A Van't Veer","year":"2013","unstructured":"Van't Veer A, Bechtholt AJ, Onvani S, Potter D, Wang Y, Liu-Chen LY, et al. Ablation of Kappa-opioid receptors from brain dopamine neurons has anxiolytic-like effects and enhances cocaine-induced plasticity. Neuropsychopharmacology. 2013;38:1585\u201397.","journal-title":"Neuropsychopharmacology"},{"key":"1548_CR58","doi-asserted-by":"publisher","first-page":"e42365.","DOI":"10.1371\/journal.pone.0042365","volume":"7","author":"EB Margolis","year":"2012","unstructured":"Margolis EB, Toy B, Himmels P, Morales M, Fields HL. Identification of rat ventral tegmental area GABAergic neurons. PLoS ONE. 2012;7:e42365.","journal-title":"PLoS ONE"},{"key":"1548_CR59","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0014-2999(93)90167-G","volume":"243","author":"DP Devine","year":"1993","unstructured":"Devine DP, Leone P, Wise RA. Mesolimbic dopamine neurotransmission is increased by administration of \u03bc-opioid receptor antagonists. Eur J Pharmacol. 1993;243:55\u201364.","journal-title":"Eur J Pharmacol"},{"key":"1548_CR60","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1152\/physrev.2001.81.1.299","volume":"81","author":"JT Williams","year":"2001","unstructured":"Williams JT, Christie MJ, Manzoni O. Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev. 2001;81:299\u2013343.","journal-title":"Physiol Rev"},{"key":"1548_CR61","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.tins.2015.01.002","volume":"38","author":"HL Fields","year":"2015","unstructured":"Fields HL, Margolis EB. Understanding opioid reward. Trends Neurosci. 2015;38:217\u201325.","journal-title":"Trends Neurosci"},{"key":"1548_CR62","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00213-006-0578-x","volume":"191","author":"KC Berridge","year":"2007","unstructured":"Berridge KC. The debate over dopamine\u2019s role in reward: the case for incentive salience. Psychopharmacology. 2007;191:391\u2013431.","journal-title":"Psychopharmacology"},{"key":"1548_CR63","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.neuron.2012.10.021","volume":"76","author":"JD Salamone","year":"2012","unstructured":"Salamone JD, Correa M. The mysterious motivational functions of mesolimbic dopamine. Neuron. 2012;76:470\u201385.","journal-title":"Neuron"},{"key":"1548_CR64","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1523\/JNEUROSCI.3422-03.2004","volume":"24","author":"JC Pruessner","year":"2004","unstructured":"Pruessner JC, Champagne F, Meaney MJ, Dagher A. Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care: a positron emission tomography study using [11C] raclopride. J Neurosci. 2004;24:2825\u201331.","journal-title":"J Neurosci"},{"key":"1548_CR65","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/ejn.13436","volume":"45","author":"S Steidl","year":"2017","unstructured":"Steidl S, Wang H, Ordonez M, Zhang S, Morales M. Optogenetic excitation in the ventral tegmental area of glutamatergic or cholinergic inputs from the laterodorsal tegmental area drives reward. Eur J Neurosci. 2017;45:559\u201371.","journal-title":"Eur J Neurosci"},{"key":"1548_CR66","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nature08028","volume":"459","author":"M Matsumoto","year":"2009","unstructured":"Matsumoto M, Hikosaka O. Two types of dopamine neuron distinctly convey positive and negative motivational signals. Nature. 2009;459:837\u201341.","journal-title":"Nature"},{"key":"1548_CR67","doi-asserted-by":"publisher","first-page":"14220","DOI":"10.1523\/JNEUROSCI.2277-15.2015","volume":"35","author":"WM Pauli","year":"2015","unstructured":"Pauli WM, Larsen T, Collette S, Tyszka JM, Seymour B, O'Doherty JP. Distinct contributions of ventromedial and dorsolateral subregions of the human substantia nigra to appetitive and aversive learning. J Neurosci. 2015;35:14220\u201333.","journal-title":"J Neurosci"},{"key":"1548_CR68","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1523\/JNEUROSCI.1353-16.2016","volume":"37","author":"PL Brown","year":"2017","unstructured":"Brown PL, Palacorolla H, Brady D, Riegger K, Elmer GI, Shepard PD. Habenula-induced inhibition of midbrain dopamine neurons is diminished by lesions of the rostromedial tegmental nucleus. J Neurosci. 2017;37:217\u201325.","journal-title":"J Neurosci"},{"key":"1548_CR69","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/nature05860","volume":"447","author":"M Matsumoto","year":"2007","unstructured":"Matsumoto M, Hikosaka O. Lateral habenula as a source of negative reward signals in dopamine neurons. Nature. 2007;447:1111\u20135.","journal-title":"Nature"},{"key":"1548_CR70","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1152\/jn.00305.2016","volume":"116","author":"PL Brown","year":"2016","unstructured":"Brown PL, Shepard PD. Functional evidence for a direct excitatory projection from the lateral habenula to the ventral tegmental area in the rat. J Neurophysiol. 2016;116:1161\u201374.","journal-title":"J Neurophysiol"},{"key":"1548_CR71","doi-asserted-by":"publisher","first-page":"R873","DOI":"10.1016\/j.cub.2016.08.051","volume":"26","author":"VMK Namboodiri","year":"2016","unstructured":"Namboodiri VMK, Rodriguez-Romaguera J, Stuber GD. The habenula. Curr Biol. 2016;26:R873\u2013R877.","journal-title":"Curr Biol"},{"key":"1548_CR72","doi-asserted-by":"publisher","first-page":"e0159097.","DOI":"10.1371\/journal.pone.0159097","volume":"11","author":"EB Margolis","year":"2016","unstructured":"Margolis EB, Fields HL. Mu opioid receptor actions in the lateral habenula. PLoS ONE. 2016;11:e0159097.","journal-title":"PLoS ONE"},{"key":"1548_CR73","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41586-020-2158-3","volume":"580","author":"N Li","year":"2020","unstructured":"Li N, Jasanoff A. Local and global consequences of reward-evoked striatal dopamine release. Nature. 2020;580:239\u201344.","journal-title":"Nature"},{"key":"1548_CR74","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0091-3057(97)00550-9","volume":"60","author":"MJ Sepulveda","year":"1998","unstructured":"Sepulveda MJ, Hernandez L, Rada P, Tucci S, Contreras E. Effect of precipitated withdrawal on extracellular glutamate and aspartate in the nucleus accumbens of chronically morphine-treated rats: an in vivo microdialysis study. Pharmacol Biochem Behav. 1998;60:255\u201362.","journal-title":"Pharmacol Biochem Behav"},{"key":"1548_CR75","doi-asserted-by":"publisher","first-page":"7033","DOI":"10.1523\/JNEUROSCI.18-17-07033.1998","volume":"18","author":"B Chieng","year":"1998","unstructured":"Chieng B, Williams JT. Increased opioid inhibition of GABA release in nucleus accumbens during morphine withdrawal. J Neurosci. 1998;18:7033\u20139.","journal-title":"J Neurosci"},{"key":"1548_CR76","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.pbb.2013.04.015","volume":"109","author":"NM Neugebauer","year":"2013","unstructured":"Neugebauer NM, Einstein EB, Lopez MB, McClure-Begley TD, Mineur YS, Picciotto MR. Morphine dependence and withdrawal induced changes in cholinergic signaling. Pharmacol Biochem Behav. 2013;109:77\u201383.","journal-title":"Pharmacol Biochem Behav"},{"key":"1548_CR77","doi-asserted-by":"publisher","first-page":"4031","DOI":"10.1002\/hbm.22895","volume":"36","author":"RC Lorenz","year":"2015","unstructured":"Lorenz RC, Gleich T, Buchert R, Schlagenhauf F, K\u00fchn S, Gallinat J. Interactions between glutamate, dopamine, and the neuronal signature of response inhibition in the human striatum. Hum Brain Mapp. 2015;36:4031\u201340.","journal-title":"Hum Brain Mapp"},{"key":"1548_CR78","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1080\/00952990802385781","volume":"34","author":"G-F Zhang","year":"2008","unstructured":"Zhang G-F, Ren YP, Sheng LX, Chi Y, Du WJ, Guo S, et al. Dysfunction of the hypothalamic\u2013pituitary\u2013adrenal axis in opioid dependent subjects: effects of acute and protracted abstinence. Am J Drug Alcohol Abus. 2008;34:760\u20138.","journal-title":"Am J Drug Alcohol Abus"},{"key":"1548_CR79","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1210\/endo-129-2-959","volume":"129","author":"W Adamson","year":"1991","unstructured":"Adamson W, Windh R, Blackford S, Kuhn C. Ontogeny of \u03bc-and \u03ba-opiate receptor control of the hypothalamo-pituitary-adrenal axis in rats. Endocrinology. 1991;129:959\u201364.","journal-title":"Endocrinology"},{"key":"1548_CR80","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.psyneuen.2011.03.019","volume":"36","author":"GS Wand","year":"2011","unstructured":"Wand GS, Weerts EM, Kuwabara H, Frost JJ, Xu X, McCaul ME. Naloxone-induced cortisol predicts mu opioid receptor binding potential in specific brain regions of healthy subjects. Psychoneuroendocrinology. 2011;36:1453\u20139.","journal-title":"Psychoneuroendocrinology"},{"key":"1548_CR81","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1369-1600.2011.00430.x","volume":"18","author":"GS Wand","year":"2013","unstructured":"Wand GS, Weerts EM, Kuwabara H, Wong DF, Xu X, McCaul ME. The relationship between naloxone\u2010induced cortisol and delta opioid receptor availability in mesolimbic structures is disrupted in alcohol\u2010dependent subjects. Addict Biol. 2013;18:181\u201392.","journal-title":"Addict Biol"},{"key":"1548_CR82","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/sj.npp.1300667","volume":"30","author":"LM Oswald","year":"2005","unstructured":"Oswald LM, Wong DF, McCaul M, Zhou Y, Kuwabara H, Choi L, et al. Relationships among ventral striatal dopamine release, cortisol secretion, and subjective responses to amphetamine. Neuropsychopharmacology. 2005;30:821\u201332.","journal-title":"Neuropsychopharmacology"},{"key":"1548_CR83","doi-asserted-by":"publisher","first-page":"e0150729","DOI":"10.1371\/journal.pone.0150729","volume":"11","author":"J Yang","year":"2016","unstructured":"Yang J, Li J, Xu G, Zhang J, Chen Z, Lu Z, et al. Elevated hair cortisol levels among heroin addicts on current methadone maintenance compared to controls. PLoS ONE. 2016;11:e0150729.","journal-title":"PLoS ONE"},{"key":"1548_CR84","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/00004647-199601000-00005","volume":"16","author":"AA Lammertsma","year":"1996","unstructured":"Lammertsma AA, Bench CJ, Hume SP, Osman S, Gunn K, Brooks DJ, et al. Comparison of methods for analysis of clinical [11C] raclopride studies. J Cereb Blood Flow Metab. 1996;16:42\u201352.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1548_CR85","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00008877-199505001-00117","volume":"6","author":"T Shippenburg","year":"1995","unstructured":"Shippenburg T, Bals-Kubik R. Involvement of the mesolimbic dopamine system in mediating the aversive effects of opioid antagonists in the rat. Behav Pharmacol. 1995;6:99\u2013106.","journal-title":"Behav Pharmacol"},{"key":"1548_CR86","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.neubiorev.2017.09.022","volume":"83","author":"S Steidl","year":"2017","unstructured":"Steidl S, Wasserman DI, Blaha CD, Yeomans JS. Opioid-induced rewards, locomotion, and dopamine activation: a proposed model for control by mesopontine and rostromedial tegmental neurons. Neurosci Biobehav Rev. 2017;83:72\u201382.","journal-title":"Neurosci Biobehav Rev"},{"key":"1548_CR87","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fnins.2011.00071","volume":"5","author":"MR Delgado","year":"2011","unstructured":"Delgado MR, Jou RL, Phelps EA. Neural systems underlying aversive conditioning in humans with primary and secondary reinforcers. Front Neurosci. 2011;5:71\u201371.","journal-title":"Front Neurosci"},{"key":"1548_CR88","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.neuron.2010.03.002","volume":"66","author":"MN Baliki","year":"2010","unstructured":"Baliki MN, Geha PY, Fields HL, Apkarian AV. Predicting value of pain and analgesia: nucleus accumbens response to noxious stimuli changes in the presence of chronic pain. Neuron. 2010;66:149\u201360.","journal-title":"Neuron"},{"key":"1548_CR89","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1152\/jn.2000.84.6.3072","volume":"84","author":"MR Delgado","year":"2000","unstructured":"Delgado MR, Nystrom LE, Fissell C, Noll DC, Fiez JA. Tracking the Hemodynamic Responses To Reward And Punishment In The Striatum. J Neurophysiol. 2000;84:3072\u20137.","journal-title":"J Neurophysiol"},{"key":"1548_CR90","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1037\/pha0000453","volume":"29","author":"JJ Mahoney III","year":"2021","unstructured":"Mahoney JJ III, Haut MW, Hodder SL, Zheng W, Lander LR, Berry JH, et al. Deep brain stimulation of the nucleus accumbens\/ventral capsule for severe and intractable opioid and benzodiazepine use disorder. Exp Clin Psychopharmacol. 2021;29:210\u20135.","journal-title":"Exp Clin Psychopharmacol"},{"key":"1548_CR91","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1159\/000468001","volume":"8","author":"J Karkalas","year":"1973","unstructured":"Karkalas J, Lal H. A comparison of haloperidol with methadone in blocking heroin-withdrawal symptoms. Int Pharmacopsychiatry. 1973;8:248\u201351.","journal-title":"Int Pharmacopsychiatry"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01548-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01548-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01548-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T15:15:04Z","timestamp":1725722104000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01548-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,1]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["1548"],"URL":"https:\/\/doi.org\/10.1038\/s41398-021-01548-8","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,1]]},"assertion":[{"value":"14 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"445"}}